Delivery Order SPE2DR25D2006-SPE2DR26F56CG
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,655.63 to AmerisourceBergen Drug Corp for the supply of Azathioprine 50 mg tablets (100 count) on August 13, 2025, with completion expected by August 14, 2025. This non-competitive, firm fixed-price delivery order was issued under a child contract mechanism and represents a routine pharmaceutical procurement for federal medical supply needs. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Azathioprine 50 mg tablets (100-count units) under a firm fixed price contract with a ceiling value of $3,600.48. This non-set-aside, competitively awarded delivery order is set for ultimate completion on August 11, 2025, and represents a continuation of the company's pharmaceutical supply support to federal healthcare systems. The work will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order on August 11, 2025, for the supply of Azathioprine 50 mg tablets in quantities of 100 units at a ceiling value of $2,275.62. This was a competitively awarded, firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for azathioprine 100 mg tablets (100 count) on September 24, 2025, with a ceiling value of $2,122.54 and ultimate completion date of September 25, 2025. This competitively awarded, firm fixed price delivery order was fulfilled from the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. The contract carries no set-aside designation. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Azathioprine 50 mg tablets in quantities of 100 per unit, with a ceiling value of $2,435.67. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion by July 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Azathioprine 50 mg tablets (100 count) with a ceiling value of $1,780.72. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation and represents a routine pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Azathioprine 50 mg tablets in quantities of 100 units, valued at $5,234.40. This is a firm fixed price delivery order issued under a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Azathioprine 50 mg tablets (100-count) under a firm fixed-price contract valued at $3,469.06. This is a non-set-aside award issued as a child delivery order, with performance at the contractor's Conshohocken, Pennsylvania facility and an ultimate completion date of August 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Azathioprine 50 mg tablets in quantities of 100 units at a ceiling value of $2,056.22. This non-competitive, firm fixed-price delivery order is set to be completed by August 4, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value pharmaceutical procurement under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Azathioprine 50 mg tablets in quantities of 100 units at a firm fixed price of $1,220.68. This award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside designation and is scheduled...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F56CGDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Azathioprine 100 mg tablets (100-count units) with a ceiling value of $1,794.82. This non-competitive, firm fixed-price delivery order, issued on November 17, 2025, is set to conclude by November 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply requirements. This delivery order operates under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor serving the Defense Health Agency and broader federal healthcare systems, AmerisourceBergen leverages this comprehensive IDC vehicle to deliver a wide range of pharmaceutical products, including brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support military and veteran healthcare programs globally. The company's consistent receipt of competitively awarded delivery orders demonstrates its established capability to meet federal pharmaceutical procurement requirements efficiently.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 11/17/25 |